期刊文献+

外周血中miRNAs作为乳腺癌肿瘤标志物的研究进展 被引量:3

下载PDF
导出
摘要 由于乳腺癌的高发病率、死亡率及现有检查手段的局限性,探寻新的乳腺癌肿瘤标志物成为近来的研究热点。特异性miRNAs在乳腺细胞中的差异性表达在乳腺癌发生发展中起重要作用,这些差异性表达的miRNAs能被选择性地释放至外周血中,由此外周血中的miRNAs可能成为一种新的乳腺癌肿瘤标志物用于乳腺癌筛查、疗效分析和预后。现就外周血中miRNAs作为乳腺癌肿瘤标志物的研究进展作一综述。
出处 《临床外科杂志》 2014年第12期956-958,共3页 Journal of Clinical Surgery
基金 国家自然基金面上项目资助(项目编号81374024) 湖北省自然科学基金一般项目资助
  • 相关文献

参考文献2

二级参考文献21

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献1013

同被引文献35

  • 1郑航,罗荣城.TPS、CA-153和CEA联合检测对乳腺癌的诊断价值[J].第一军医大学学报,2005,25(10):1293-1294. 被引量:46
  • 2Oike Y, Yasunaga K, Suda T. Angiopoietin-related/angiopoietinlike proteins regulate angiogenesis [J]. lnt J Hematol, 2004,80 ( 1 ) : 21- 28.
  • 3Ide S, Toiyama Y, Shimura T, et al. Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with E- sophageal Cancer [ J]. Ann Surg Onco1,2015,22(8) :2585-2592.
  • 4Gao L, Ge C, Fang T, et al. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma [J]. J Gastroenterol Hepatol, 2015,30 ( 2 ) : 396-404.
  • 5Shimura T, Toiyama Y, Tanaka K, et al. Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer E J 1. Anticancer Res ,2015,35 ( 9 ) :4633-4639.
  • 6Masuda T, Endo M, Yamamoto Y, et al. ANGPTL2 increases bone me- tastasis of breast cancer cells through enhancing CXCR4 signaling [ J]. Sci Rep,2015 ,5 :9170.
  • 7Endo M, Yamamoto Y, Nakano M, et al. Serum ANGPTL2 levels re- flect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis [ J ]. Int J Biol Markers,2014, 29 ( 3 ) : e239-e245.
  • 8Wicha MS, Hayes DF. Circulating Tumor Cells : Not All Detected Cells Are Bad and Not All Bad Cells Are Detected [ J ]. JClin 0ncol,2011,29 (12) : 1508-1511.
  • 9Harouaka R,Kang Z,Zheng SY,et al. Cir- culating tumor cells : Advances in isolation and analysis, and challenges for c,inical applications [ J ]. Pharmacol Ther, 2014, 141 (2) :209-221.
  • 10Serrano M J, Rovira PS, Martfnezzubiaurrc I, et al. Dynamics of circulating tumor cells in early breast cancer under neoad- juvant therapy[ J]. Exp Ther Med,2012, 4(1) :43-48.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部